Effect of lactation on postpartum cardiac function of pregnancy-associated hypertensive mice

Endocrinology

Volumn 154, Issue 2, 2013, Pages 597-602

  Murata, Kazuya ^a   Saito, Chiaki ^a   Ishida, Junji ^a   Hamada, Juri ^a   Sugiyama, Fumihiro ^a   Yagami, Ken Ichi ^a   Fukamizu, Akiyoshi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FIBROSIS; GENE EXPRESSION; GESTATIONAL AGE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE CONTRACTILITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LACTATION; MACROPHAGE INFILTRATION; MALE; MATERNAL HYPERTENSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PUERPERIUM; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE;

ANIMALS; CARDIOMEGALY; FEMALE; FIBROSIS; HUMANS; HYPERTENSION; LACTATION; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL CONTRACTION; POSTPARTUM PERIOD; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 84872712178     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1789     Document Type: Article

References (29)

1. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631-644.
2. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974-982.
3. Fraser A, Nelson SM, Macdonald-Wallis C, et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon longitudinal study of parents and children. Circulation. 2012;125:1367-1380.
4. Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111:2050-2055. (Pubitemid 40577899)
5. Wilson LA, Mills SE, Finley E, Kilgour E, Buttery PJ, Vernon RG. Effect of lactation on insulin signal transduction in sheep adipose tissue and skeletal muscle. J Endocrinol. 1996;151:469-480. (Pubitemid 26405595)
6. Pedraza N, Solanes G, Carmona MC, et al. Impaired expression of the uncoupling protein-3 gene in skeletal muscle during lactation: fibrates and troglitazone reverse lactation-induced downregulation of the uncoupling protein-3 gene. Diabetes. 2000;49:1224-1230. (Pubitemid 30439099)
7. Gutgesell A, Ringseis R, Schmidt E, Brandsch C, Stangl GI, Eder K. Downregulation of peroxisome proliferator-activated receptor alpha and its coactivators in liver and skeletal muscle mediates the metabolic adaptations during lactation in mice. J Mol Endocrinol. 2009;43:241-250.
8. Wang X, Hole DG, Da Costa TH, Evans RD. Alterations in myocardial lipid metabolism during lactation in the rat. Am J Physiol. 1998;275:E265-E271.
9. Schwarz EB, Ray RM, Stuebe AM, et al. Duration of lactation and risk factors for maternal cardiovascular disease. Obstet Gynecol. 2009;113:974-982.
10. Safirstein JG, Ro AS, Grandhi S, Wang L, Fett JD, Staniloae C. Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int J Cardiol. 2012;154:27-31.
11. Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007;128:589-600. (Pubitemid 46206082)
12. Takimoto E, Ishida J, Sugiyama F, Horiguchi H, Murakami K, Fukamizu A Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science. 1996;274:995-998. (Pubitemid 26398424)
13. Saito T, Ishida J, Takimoto-Ohnishi E, et al. An essential role for angiotensin II type 1a receptor in pregnancy-associated hypertension with intrauterine growth retardation. FASEB J. 2004;18:388-390.
14. Takimoto-Ohnishi E, Saito T, Ishida J, et al. Differential roles of renin and angiotensinogen in the feto-maternal interface in the development of complications of pregnancy. Mol Endocrinol. 2005;19:1361-1372. (Pubitemid 40594130)
15. Sakairi A, Ishida J, Honjo K, et al. Angiotensin type 1 receptor blockade prevents cardiac remodeling in mice with pregnancy-associated hypertension. Hypertens Res. 2008;31:2165-2175.
16. Bush E, Maeda N, Kuziel WA, et al. CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension. Hypertension. 2000;36:360-363.
17. Schrader LI, Kinzenbaw DA, Johnson AW, Faraci FM, Didion SP. IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. ArteriosclerThrombVasc Biol. 2007;27:2576-2581. (Pubitemid 350158908)
18. Sriramula S, Haque M, Majid DS, Francis J. Involvement of tumor necrosis factor-α in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension. 2008;51:1345-1351. (Pubitemid 351555948)
19. Qi G, Jia L, Li Y, et al. Angiotensin II infusion-induced inflammation, monocytic fibroblast precursor infiltration, and cardiac fibrosis are pressure dependent. Cardiovasc Toxicol. 2011;11:157-167.
20. Nahmod KA, Walther T, Cambados N, et al. AT1 receptor blockade delays postlactational mammary gland involution: a novel role for the renin angiotensin system. FASEB J. 2012;26:1982-1994.
21. Brogan RS, Mitchell SE, Trayhurn P, Smith MS. Suppression of leptin during lactation: contribution of the suckling stimulus versus milk production. Endocrinology. 1999;140:2621-2627. (Pubitemid 32245139)
22. Xiao XQ, Grove KL, Smith MS. Metabolic adaptations in skeletal muscle during lactation: complementary deoxyribonucleic acid microarray and real-time polymerase chain reaction analysis of gene expression. Endocrinology. 2004;145:5344-5354. (Pubitemid 39551156)
23. Saltzberg MT, Szymkiewicz S, Bianco NR. Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator. J Card Fail. 2012;18:21-27.
24. Goland S, Bitar F, Modi K, et al. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Card Fail. 2011;17:426-430.
25. Kamiya CA, Kitakaze M, Ishibashi-Ueda H, et al. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders: results from the Japanese Nationwide survey of peripartum cardiomyopathy. Circ J. 2011;75:1975-1981.
26. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649-658.
27. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12:642-649. (Pubitemid 43865232)
28. Patten IS, Rana S, Shahul S, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012;485:333-338.
29. Furuya M, Ishida J, Inaba S, et al. Impaired placental neovascularization in mice with pregnancy-associated hypertension. Lab Invest. 2008;88:416-429. (Pubitemid 351432779)